MedPath

Nigella Sativa Oil Extract and Xenograft Bone Graft in Treatment of Infra-bony Defects

Phase 2
Conditions
Localized Aggressive Periodontitis
Interventions
Procedure: periodontal regenerative surgery
Registration Number
NCT04722380
Lead Sponsor
Tanta University
Brief Summary

The aim of this study will be to evaluate, clinically, and radiographically the effect of Nigella Sativa oil extract Mixed with xenograft versus xenograft alone in the treatment of intra-bony defects in patients with aggressive periodontitis.

Detailed Description

in 10 patients, twenty sites in subjects with, localized aggressive periodontitis, with CAL ≥ 5 will be included in the present study. Sites will be allocated randomly to be surgically treated with, Nigella Sativa oil extract Mixed with xenograft or xenograft alone. At baseline, 3, 6 after surgery, the following clinical parameters (PD, CAL, BOP) and CBCT at baseline and 6 months x-ray will be recorded.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
10
Inclusion Criteria
  • systemically healthy patients were selected

    • patients who had not received any medications for the previous six months that may interfere with periodontal tissue health or healing.
    • Patients should demonstrate their ability to maintain good oral hygiene
Exclusion Criteria
  • • Smokers and pregnant patients.

    • Medically compromised patients and systemic conditions precluding periodontal surgery.
    • Subjects who do not comply with oral hygiene measures as evidenced in recall visits.
    • Restoration or caries in the site to be treated or non-vital tooth
    • Restoration or caries in the site to be treated or non-vital tooth

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
test groupperiodontal regenerative surgery10 infrabony defects treated surgically with Nigella Sativa oil extract Mixed with xenograft
control groupperiodontal regenerative surgery10 infrabony defects treated surgically with xenograft alone
Primary Outcome Measures
NameTimeMethod
clinical attachment level6 months

clinical attachment level will be recorded at baseline, 3, and 6 months at the site to be treated

probing pocket depth6 months

probing pocket depth probing pocket depth will be recorded at baseline, 3, and 6 months at the site to be treated

bleeding on probing6 months

bleeding on probing will be recorded at baseline, 3, and 6 months at the site to be treated

cone beam x ray measuring bone fill6 months

bone fill will be recorded at baseline, and 6 months at the site to be treated

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Doaa Ahmed yousef bayoumi

🇪🇬

Tanta, Gharbiya, Egypt

© Copyright 2025. All Rights Reserved by MedPath